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Abstract
Purpose—Coronary Computed Tomography Angiography (CCTA) contrast opacification
gradients, or Transluminal Attenuation Gradients (TAG) offer incremental value to predict
functionally significant lesions. This study introduces and evaluates an automated gradients
software package that can potentially supplant current, labor-intensive manual TAG calculation
methods.
Methods—All 60 major coronary arteries in 20 patients who underwent a clinically indicated
single heart beat 320×0.5 mm detector row CCTA were retrospectively evaluated by two readers
using a previously validated manual measurement approach and two additional readers who used
the new automated gradient software. Accuracy of the automated method against the manual
measurements, considered the reference standard, was assessed via linear regression and Bland-
Altman analyses. Inter- and intra-observer reproducibility and factors that can affect accuracy or
reproducibility of both manual and automated TAG measurements, including CAD severity and
iterative reconstruction, were also assessed.
Results—Analysis time was reduced by 68% when compared to manual TAG measurement.
There was excellent correlation between automated TAG and the reference standard manual TAG.
Bland-Altman analyses indicated low mean differences (1 HU/cm) and narrower inter- and intra-
observer limits of agreement for automated compared to manual measurements (25% and 36%
reduction with automated software, respectively). Among patient and technical factors assessed,
none affected agreement of manual and automated TAG measurement.
Address for Correspondence: Dimitrios Mitsouras, PhD, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115,
Phone: 617-732-7206, Fax: 617-264-5245, dmitsouras@partners.org.
Conflicts of interest: Mr. Schultz and Dr. Mather are employees of Toshiba Medical Research Institute, USA. Ms. Fujisawa is an
employee of Toshiba Medical Systems Corporation. Dr. Rybicki receives support from Toshiba Medical Systems Corporation.
NIH Public Access
Author Manuscript
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
Published in final edited form as:
Int J Cardiovasc Imaging. 2014 August ; 30(6): 1181–1189. doi:10.1007/s10554-014-0446-4.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Conclusion—Automated 320×0.5 mm detector row gradient software reduces computation time
by 68% with high accuracy and reproducibility.
Keywords
Coronary CT Angiography; Cardiac Imaging; Hounsfield units; Contrast Opacification Gradients;
Transluminal attenuation gradient
Introduction
While coronary CT angiography (CCTA) utilization increases, it remains limited because of
challenges in identifying the hemodynamic significance of individual lesions (1, 2).
Growing evidence supports the initial observation that coronary blood flow information can
be obtained from CCTA using contrast opacification variations (3–6). The contrast
opacification gradient, or transluminal attenuation gradient (TAG) (7) computes a linear
regression of the CT density (Hounsfield units [HU]) versus distance along the length of a
coronary artery to summarize the proximal to distal variation in coronary contrast
opacification in a standard CCTA acquisition.
The literature on TAG (3, 4, 6, 8, 9) has reported mixed results; some strongly support its
use as a simple adjunct to CCTA while others suggest it has limited value. The TAG is
influenced by scanner hardware, physiological parameters, as well as the measurement
technique itself. This work addresses potential variability due to lack of a standardized
measurement method. In the initial gradient technique, Steigner et al (7) used customized
software to analyze vessels at 0.5 mm intervals along the coronary centerline to 2.5 mm
luminal diameter distally. Choi et al (3, 8) and Yoon et al (9) instead manually measured
opacification at 5 mm intervals but to a distal cutoff defined by 2 mm2 lumen area. Wong et
al (6) also followed the same 5 mm interval manual approach and 2 mm2 cutoff, but defined
coronary opacification using 1 mm2 luminal regions of interest (ROI).
This study introduces new automated software for TAG measurement and investigates its
accuracy against manual TAG measurement. We also test the hypothesis that automated
calculation reduces inter-observer and intra-observer variability compared to manual TAG,
and finally we investigate the effect of different patient-, artery-, and scan-related
parameters on the agreement between automated and manual TAG, as well as on their
reproducibility.
Methods
Image acquisition and image reconstruction
The institutional human research committee approved this HIPAA-compliant retrospective
study; informed consent was waived. We assessed gradients in twenty randomly selected
intermediate risk patients (Table 1) imaged with first generation single R–R 320 × 0.5 mm
detector row (Aquilion ONE, Toshiba Medical Systems Corporation, Tochigi, Japan) CCTA
at our institution between September 2012 and September 2013. Beta blockers were
administered orally and/or intravenously with a target heart rate of ≤65 beats per minute.
Contrast (60–70 ml iopamidol 370 mg iodine/ml, [Isovue 370, Bracco Diagnostics,
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Princeton, NJ]) followed by saline (40 ml) were injected at a rate of 6 ml/s with a dual-
syringe injector (Empower Plus CTA, Bracco Diagnostics, Princeton, NJ). CCTA
acquisition was timed by bolus tracking (180 HU) in the descending aorta. Most cases used
prospective ECG triggering at 65–85% of the R–R interval (10). Radiation dose was
estimated from the dose-length product using a conversion factor of 0.014 mSv/mGy-cm.
Images were reconstructed at 0.5 mm slice thickness with 0.25 mm overlap using an
iterative (AIDR3D) algorithm (11) and default coronary reconstruction kernel (FC03). For
those 15 patients with available “raw” sinogram data, images were additionally
reconstructed using conventional filtered back-projection (FBP), keeping all other
reconstruction parameters identical.
Gradient measurements
Four readers evaluated TAG in the major coronary arteries (left anterior descending [LAD],
left circumflex artery [LCx], and right coronary artery to the posterolateral branch [RCA]) in
AIDR3D reconstructions. One week later, each reader evaluated TAG in the 15 patients with
FBP reconstructions. Finally, another week later, each reader revaluated TAG in the first 10
AIDR3D reconstructions. All readers were blinded to each other’s measurements. Two of
the readers used the new automated gradient software (Toshiba Medical Systems
Corporation, Tochigi, Japan) and the other two manually obtained the gradient using an
image post-processing workstation (Vitrea 6.4, Vital Images, A Toshiba Medical Systems
Group, Minnetonka, MN) following the method described by Wong et al (6). All readers
timed the duration of analysis for each artery.
Automated gradient calculations
Each cardiovascular imager placed seed points for automated coronary centerline detection
and performed manual correction in multi-planar reformations (MPR) as needed. The
software then automatically generated cross-sectional images every 1 mm perpendicular to
the centerline (Figure 1A). Next, each reader used sliders in the MPR view to place two
gradient “landmarks”, one proximally at the coronary ostium and one distally where lumen
diameter tapered to <2 mm2. The software reported the TAG between landmarks using the
average HU in 3×3-pixel blocks centered at the centerline in each cross-sectional image.
Assuming typical 0.35 mm in-plane resolution, the 3×3-pixel block approximates a circular
1mm2 ROI as described by Wong et al (6).
Manual gradient calculations
Each reader similarly defined and manually corrected the centerline, and identified the same
two landmark locations (Figure 1B). Manually positioned 1 mm2 ROIs in the coronary
lumen were then placed in cross-sectional images perpendicular to the coronary artery
centerline every 5 mm between the two landmarks. The location and average HU of each
ROI were then manually transcribed and the TAG was calculated as the slope of the linear
regression analysis.
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Accuracy, inter-observer agreement and reproducibility of automated gradients
Using the manually-derived TAG as reference, automated TAG accuracy was assessed using
all vessels in the 20 patients with AIDR3D reconstructions. Inter-observer reproducibility of
manual and automated TAG was also assessed from this data. Intra-observer reproducibility
for each reader independently was assessed from the repeat TAG measurements performed
two weeks after the initial measurements. The time interval between the initial and repeat
measurement was considered adequate to minimize recall bias. We further investigated five
factors that can potentially influence TAG accuracy and inter- and intra-observer agreement:
coronary artery, body mass index (BMI), presence and severity of CAD, plaque
composition, and image reconstruction algorithm. CAD severity was classified by both
CCTA, as well as a reference standard when available. Details are provided in Table 2.
Statistical analysis
Analyses were performed in GraphPad Prism 6.0 (GraphPad Inc., San Diego, CA). Results
are expressed as mean±standard error of mean or median and interquartile range.
Comparisons of means among normally distributed variables were performed with the
Student’s t-test, or one way analysis of variances (ANOVA) with Tukey’s test to correct for
multiple comparisons. Comparisons of means among non-normally distributed variables
were performed with the Wilcoxon matched-pairs signed rank test and Friedman test for
paired data, as well as the Kruskal-Wallis test for non-paired data. The Dunn’s test was
further used to correct for multiple comparisons. For the method comparison study of
automated versus manual assessment, as well as for reproducibility of automated and
manual TAG calculations, Bland-Altman analysis and linear regression analysis with
Spearman correlation were performed (12). In Bland-Altman plots, the difference between
corresponding measurements (y-axis) was plotted against their mean (x-axis). The bias and
limits of agreement (mean±1.96×standard deviation [SD]) were calculated. The automated
method was considered to agree with the manual measurements when the mean difference
and the limits of agreement between the automated and manual analysis were comparable or
better than the inter- and intra-observer agreement of the manual TAG measurements. A p-
value ≤0.05 was considered significant.
Results
There were no automated software failures. For the timed measurements (n=30 arteries), the
analysis time per artery was 68% less for the automated software (4.2±0.3 vs. 13.0±0.7 min/
artery, p<0.001). Considering all 60 vessels, the difference between the mean of the
automated TAG (−24.2, IQR: [−41.0, −15.8]) and the manual TAG (−25.2, IQR [−38.5,
−16.1]) was less than 1 HU/cm and was not significantly different (p=0.10). Bland-Altman
analysis (Figure 1C) showed a bias of 1.0HU/cm and limits of agreement ranging from
−15.6 to 17.6 HU/cm. Linear regression analysis (Figure 1D) indicated a unit slope and
small intercept (y=1.0x+2.0 HU/cm, r=0.92, p<0.001), further supporting the agreement of
the two approaches.
Considering all 60 arteries, there was high inter-observer agreement for both automated
(linear regression y=1.1x+3.3, r=0.92, p<0.001) and manual (y=1.1x+1.9, r=0.90, p<0.001)
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TAG; Bland-Altman plots revealed slightly lower bias and narrower limits of agreement for
automated versus manual gradient measurements (Figure 2). Intra-observer reproducibility
was very high for both automated and manual approaches (Figure 3); automated
measurements had narrower limits of agreement and higher correlation coefficients (r=0.93
for both readers, p<0.001) compared to manual (r=0.84 and 0.91 for readers 1 and 2,
respectively, both p<0.001) TAG measurements (Figure 3).
There was no difference between automated and manual TAG (Table 2) across BMI
categories, presence and severity of CAD, plaque composition, or reconstruction algorithm.
Although not significantly different, agreement between automated and manual gradients
was reduced in the LCx compared to LAD and RCA. This was reflected in wider limits of
agreement for the LCx (−24.7 to 19.9 HU/cm, compared to −9.3 to 12.8 HU/cm for the LAD
and −9.1 to 16.4 HU/cm for the RCA). None of the parameters studied influenced either
inter-observer agreement or intra-observer reproducibility of automated TAG measurements.
For manual TAG, only BMI influenced intra-observer reproducibility (Table 2).
Discussion
This study introduced automated gradient software and provides, to our knowledge, the
initial study of gradient variability due to measurement strategy. While we only considered
20 patients that span several indications for CCTA, a strength of this work is the
comprehensive assessment over multiple readers. An accurate automated gradient software
package can be implemented into clinical practice with a 68% time savings with respect to
manual ROI measurements. Moreover, the automated system slightly improves the inter-
and intra-observer limits of agreement.
The value of techniques such as TAG stems from the fact that CCTA remains limited largely
because it does not readily provide information regarding functional significance of
anatomical lesions. Demonstration of the hemodynamic significance of CAD, for which
invasive FFR is the accepted gold-standard (13), has proven beneficial for guiding
revascularization (2, 14). As a result, techniques are being tested to enhance CCTA with the
ability to confer functional information, thereby providing a stand-alone single-modality test
for CAD assessment and risk stratification. Among those are CT perfusion (15) and “FFR-
CT” (16, 17) which rely on either the acquisition of a second CT scan at induced hyperemia,
or the simulation of hyperemia by computational means, respectively.
Coronary opacification gradients are another approach toward extracting hemodynamic
information from CCTA. They emerged from the observation that contrast distribution at
single heart beat 320-detector row CCTA is not homogeneous along the length of a coronary
artery (7), but is instead characterized by a linear drop-off (gradient) in luminal HU along
the length of the artery (7). In an in vitro validation study, Lackner et al established that the
temporal and contrast resolution of ≥16 detector row CT indeed enables detection of flow-
induced variations in luminal HU that suffice to differentiate stenosis grade (5). Choi et al
reported the in vivo correlation of TAG to Thrombolysis in Myocardial Infarction (TIMI)
grade and additionally found incremental value in diagnostic accuracy for calcified lesions
(3). In terms of functional information at stress, Choi et al reported a low sensitivity but high
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specificity for TAG measured in 64-detector row CCTA that when added to CCTA percent
stenosis information significantly increased the area under the receiver operating
characteristic curve for the detection of abnormal invasive FFR ≤0.8 (8). Yoon et al
similarly reported a low sensitivity but high specificity of TAG from 64-detector row CCTA
for the detection of FFR ≤0.8, but did not report accuracy when added to CCTA percent
stenosis (9). More recently, Wong et al reported that TAG measured in 320-detector row
CCTA independently predicted FFR ≤0.8 and increased both the sensitivity and specificity
of CCTA percent stenosis information (6).
While gradients are conceptually simple, the manual placement of 20–100 lumen ROIs in
each coronary artery is impractical for CCTA workflow. Furthermore, TAG inter- and intra-
observer variability have been only sporadically reported, and not analyzed with respect to
the physiological and technical variations encountered at CCTA. In addition to the time
savings, the automated software resulted in lower measurement variation, both between
observers and for the same observer (25% and 36% reduction in limits of agreement,
respectively). This finding is likely due to the fact that automated software can perform HU
measurements at much more closely spaced intervals than reasonable for manual
measurement (e.g. every 1 compared to 5 mm). Using more closely spaced measurements
reduces the effect of plaque inclusion in some ROIs. Automated TAG measurements may
thus have the potential to enable increased statistical power with a reduced sample size for
the detection of significant differences with respect to a reference standard.
Furthermore, it is unknown what factors may affect TAG measurements. This study
provides evidence that observer agreement and reproducibility of TAG remains largely
unaffected within the user bias present for many common facts. Importantly, presence of
obstructive CAD and plaque composition did not alter accuracy or reproducibility of
automated TAG, suggesting the ability of the software to effectively perform in all cases.
We also found that TAG measurements are both feasible and accurate for images
reconstructed with iterative methods. A borderline significant difference in accuracy was
observed in this study for the LCx compared to the RCA, with the widest limits of
agreement found in the LCx. For future trials, it may be prudent to consider separate
comparison of coronary territories against reference standards such as FFR, and/or defining
different cutoff values for normal versus abnormal TAG per territory. We also found
gradient discrepancies (up to approximately 6 HU/ cm) among the BMI categories. While
this may be related to image noise, further study is required to assess if future gradient
measurements will require stratification with respect to patient BMI.
Limitations
For this study, the automated TAG reference standard was manual measurements performed
as previously described in the same cohort. As this study was not designed to assess imaging
findings of CAD with a reference standard, it is in theory possible that automated gradients
have different accuracy (when compared to manual gradient measurements) and
reproducibility profiles for patients with versus without CAD. Moreover, if binary cutoffs
for normal versus abnormal gradients are implemented into clinical practice, these should be
validated against a clinical reference standard for any gradient method under consideration.
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However, the sub-analyses of normal versus non-obstructive versus obstructive CAD here
provides pilot evidence that the automated measurements are likely to be accurate (when
compared to clinical standards). Larger studies using a clinical reference standard such as
FFR (6) or combined anatomy and function (15) are needed, but can in theory be simpler to
perform with the new automated TAG tool. Another limitation is that our validation
inherently applies to 320-detector row single heartbeat CCTA, in which the contrast
opacification gradient is directly related to the pace of contrast transport through the
coronaries. This and many other factors that can affect gradient reproducibility still remain
to be assessed, such as spiral vs. single heart beat CCTA, amount and rate of contrast
injection, and overall contrast bolus geometry, which in turn is also affected by systemic
cardiovascular function (18). Investigating those aspects will require larger studies but that
are again rendered more readily possible given access to a quick, automated TAG approach.
Conclusion
Coronary gradient measurements using automated software are feasible, accurate and
reproducible over several clinical and imaging-based factors. Automated gradients could
allow for more rapid assessment of the functional significance of anatomical lesions without
requiring more contrast, pharmacologic stress agents or sophisticated computational
analyses. Future studies assessing coronary gradients as a metric to determine the
hemodynamic significance of anatomical lesions can standardize gradient measurements via
such automated software so as to maximize the possibility to detect correlations to study
endpoints.
Acknowledgments
Grant Support: Grant Sponsor: National Institutes of Health, National Institute of Biomedical Imaging and
Bioengineering grant number K01-EB015868; Grant Sponsor: Behrakis Foundation, Boston, USA; Grant Sponsor:
Hellenic Cardiological Society, Athens, Greece
References
1. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous
Coronary Intervention: executive summary: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines and the Society for
Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012; 79(3):453–95.
[PubMed: 22328235]
2. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding
percutaneous coronary intervention. N Engl J Med. 2009; 360(3):213–24. [PubMed: 19144937]
3. Choi JH, Min JK, Labounty TM, et al. Intracoronary transluminal attenuation gradient in coronary
CT angiography for determining coronary artery stenosis. JACC Cardiovasc Imaging. 2011; 4(11):
1149–57. [PubMed: 22093264]
4. Chow BJ, Kass M, Gagne O, et al. Can differences in corrected coronary opacification measured
with computed tomography predict resting coronary artery flow? J Am Coll Cardiol. 2011; 57(11):
1280–8. [PubMed: 21392642]
5. Lackner K, Bovenschulte H, Stutzer H, Just T, Al-Hassani H, Krug B. In vitro measurements of
flow using multislice computed tomography (MSCT). Int J Cardiovasc Imaging. 2010
6. Wong DTL, Ko BS, Cameron JD, et al. Transluminal Attenuation Gradient in Coronary Computed
Tomography Angiography is a Novel Noninvasive Approach to the Identification of Functionally
Chatzizisis et al. Page 7
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Significant Coronary Artery Stenosis: A Comparison with Fractional Flow Reserve. J Am Coll
Cardiol. 2013; 61(12):1271–9. [PubMed: 23414792]
7. Steigner ML, Mitsouras D, Whitmore AG, et al. Iodinated contrast opacification gradients in normal
coronary arteries imaged with prospectively ECG-gated single heart beat 320-detector row
computed tomography. Circ Cardiovasc Imaging. 2010; 3(2):179–86. [PubMed: 20044512]
8. Choi JH, Koo BK, Yoon YE, et al. Diagnostic performance of intracoronary gradient-based methods
by coronary computed tomography angiography for the evaluation of physiologically significant
coronary artery stenoses: a validation study with fractional flow reserve. Eur Heart J Cardiovasc
Imaging. 2012; 13(12):1001–7. [PubMed: 22802430]
9. Yoon YE, Choi JH, Kim JH, et al. Noninvasive diagnosis of ischemia-causing coronary stenosis
using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow
reserve computed from coronary CT angiography compared to invasively measured fractional flow
reserve. JACC Cardiovasc Imaging. 2012; 5(11):1088–96. [PubMed: 23153908]
10. Steigner ML, Otero HJ, Cai T, et al. Narrowing the phase window width in prospectively ECG-
gated single heart beat 320-detector row coronary CT angiography. Int J Cardiovasc Imaging.
2009; 25(1):85–90. [PubMed: 18663599]
11. Chen MY, Steigner ML, Leung SW, et al. Simulated 50 % radiation dose reduction in coronary CT
angiography using adaptive iterative dose reduction in three-dimensions (AIDR3D). The
international journal of cardiovascular imaging. 2013; 29(5):1167–75. [PubMed: 23404384]
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of
clinical measurement. Lancet. 1986; 1(8476):307–10. [PubMed: 2868172]
13. Kakouros N, Rybicki FJ, Mitsouras D, Miller JM. Coronary pressure-derived fractional flow
reserve in the assessment of coronary artery stenoses. Eur Radiol. 2012; 23(4):958–67. [PubMed:
23179519]
14. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding
percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year
follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel
Evaluation) study. J Am Coll Cardiol. 2010; 56(3):177–84. [PubMed: 20537493]
15. Rochitte CE, George RT, Chen MY, et al. Computed tomography angiography and perfusion to
assess coronary artery stenosis causing perfusion defects by single photon emission computed
tomography: the CORE320 study. Eur Heart J. 2013
16. Koo BK, Erglis A, Doh JH, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive
fractional flow reserve computed from coronary computed tomographic angiograms. Results from
the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses
Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011; 58(19):
1989–97. [PubMed: 22032711]
17. Min JK, Leipsic J, Pencina MJ, et al. Diagnostic accuracy of fractional flow reserve from anatomic
CT angiography. Jama. 2012; 308(12):1237–45. [PubMed: 22922562]
18. Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and
approaches. Radiology. 2010; 256(1):32–61. [PubMed: 20574084]
19. de Graaf MA, Broersen A, Kitslaar PH, et al. Automatic quantification and characterization of
coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with
intravascular ultrasound virtual histology. Int J Cardiovasc Imaging. 2013; 29(5):1177–90.
[PubMed: 23417447]
Chatzizisis et al. Page 8
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
(A) Snapshot of the software performing automated TAG calculations in an LAD with
obstructive (>70%) calcified plaque proximally. User manually defines segment of interest
from left main ostium to a 2 mm2 distal landmark (white arrows), with access to centerline
editing in curved MPR and luminal contour editing in cross-sectional images. (B)
Methodology for manual TAG calculations in the same artery. User performs manual
measurement of the luminal intensity in ROIs placed within the lumen beginning at the
ostium every 5 mm along the length of the coronary artery, and statistical analysis software
is used to perform the linear regression. Accuracy of the two techniques as defined by (C)
Bland-Altman plot and (D) linear regression plot.
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Figure 2.
Inter-observer agreement of automated and manual TAG: (A) Bland-Altman plots for
automated and (B) manual TAG; (C) Linear regression analysis for automated and (D)
manual TAG.
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Figure 3.
Reproducibility of automated and manual TAG: (A, C) Bland-Altman plots for reader 1 and
2 using automated, and (E,G) for reader 3 and 4 using manual TAG methods. (B,D) Linear
regression plots for reader 1 and 2 using automated, and (F,H) for reader 1 and 2 using
manual TAG methods.
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Table 1
Study population characteristics
Demographics
 Age (years, mean±SE) 59.2±2.2
 Male (%, n) 50% (10)
 Weight (kg, mean±SE) 90.1±6.1
 Height (cm, mean±SE) 169.4±3.8
 BMI (kg/cm2, mean±SE) 29.9±1.2
 Hyperlipidemia (%, n) 60% (12)
 Diabetes mellitus (%, n) 30% (6)
 Hypertension (%, n) 60% (12)
 Obesity (%, n) 25% (5)
 Smoking (%, n) 0% (0)
 Family history (%, n) 20% (4)
LV ejection fraction (mean±SE) 56±3%
CT indication
 Chest Pain (%, n) 55% (11)
 Abnormal/equivocal test (%, n) 25% (5)
 Pre-op evaluation (%, n) 5% (1)
 Coronary aneurysm (%, n) 5% (1)
 Others (%, n) 10% (2)
CT contrast
 Total volume (ml, mean±SE) 65.8±1.6
 Contrast rate (ml/sec, mean±SE) 5.9±0.1
CT parameters
 Peak tube voltage: 120 kV 85% (17)
 100 kV 15% (3)
 Tube current (mA, mean±SE) 503±17.9
Mean HR at acquisition (bpm, mean±SE) 57±1.7
Nitroglycerin
 0.4 mg (%, n) 60% (12)
 0.8 mg (%, n) 40% (8)
Beta blockade (n) *
 None 4
 Oral 4
 <10mg iv 5
 10–20mg iv 5
 21–30mg iv 4
 >30mg iv 1
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CAD by CT
 Normal 52% (31)
 Non-obstructive CAD 25% (15)
 Obstructive CAD 23% (14)
Plaque Characteristics by CT (n=29 vessels)
 Non-calcified 55% (16)
 Calcified 45% (13)
CAD by Reference Standard (n=42 vessels)**
 Normal 48% (20)
 Non-obstructive CAD 31% (13)
 Obstructive CAD 21% (9)
DLP (mGy-cm, median, IQR) 296.8 (248.4–392.5)
Estimated dose (mSv, median, IQR) 4.2 (3.5–5.5)
SE- Standard Error, IQR- Interquartile Range
*
Three patients received both oral and IV medication β-blocker; numbers in parentheses represent treated patients.
**Confirmed by either invasive catheter angiography, nuclear myocardial perfusion imaging or stress echocardiography, performed a median of 12
(IQR, 5–39) days of CCTA. Six patients did not have a reference standard test.
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Chatzizisis et al. Page 14
Ta
bl
e 
2
Pa
ra
m
et
er
s a
ffe
ct
in
g 
ac
cu
ra
cy
, i
nt
er
-o
bs
er
ve
r v
ar
ia
bi
lit
y 
an
d 
in
tra
-o
bs
er
ve
r r
ep
ro
du
ci
bi
lit
y 
of
 m
an
ua
l a
nd
 a
ut
om
at
ed
 T
A
G
 m
ea
su
re
m
en
ts.
A
cc
ur
ac
y
M
an
ua
l
A
ut
om
at
ed
M
an
ua
l m
in
us
 A
ut
om
at
ed
In
te
r-
ob
se
rv
er
In
tra
-o
bs
er
ve
r*
In
te
r-
ob
se
rv
er
In
tra
-o
bs
er
ve
r*
Δ 
(H
u/c
m)
p
Δ 
(H
u/c
m)
p
Δ 
(H
u/c
m)
p
Δ 
(H
u/c
m)
p
Δ 
(H
u/c
m)
p
A
ll 
Pa
tie
nt
s
−
1.
0±
1.
1
1.
6±
1.
4
0.
05
±1
.2
0.
4±
1.
0
1.
0±
0.
4
BM
I (
kg
/cm
2 )
<
25
3.
1±
3.
5
0.
23
4.
9±
3.
2
0.
75
2.
5±
1.
8
0.
01
€
5.
3±
3.
7
0.
38
−
0.
4±
1.
2
0.
53
25
–3
0
−
3.
7±
1.
4
2.
5±
2.
2
−
3.
9±
1.
7
−
0.
3±
0.
5
0.
6±
0.
4
>
30
−
2.
4±
2.
0
1.
6±
1.
8
1.
5±
1.
8
−
1.
2±
2.
1
1.
8±
0.
8
C
or
on
ar
y 
ar
te
ry
LA
D
−
1.
7±
1.
3
0.
05
2.
0±
1.
1
0.
62
−
1.
1±
1.
1
0.
85
−
0.
1±
0.
7
0.
32
0.
7±
0.
5
0.
16
LC
X
2.
4±
2.
5¶
1.
6±
3.
6
2.
6±
2.
6
3.
0±
2.
4
0.
7±
1.
0
R
CA
−
3.
6±
1.
5
1.
1±
2.
0
−
1.
3±
1.
9
−
1.
7±
1.
9
1.
6±
0.
8
Pr
es
en
ce
 a
nd
 se
ve
ri
ty
 o
f C
A
D
 b
y 
C
T♯
N
or
m
al
−
2.
1±
1.
8
0.
10
1.
1±
2.
5
0.
43
−
2.
0±
1.
4
0.
14
−
0.
4±
1.
7
0.
29
1.
5±
0.
7
0.
16
N
on
- o
bs
tru
ct
iv
e
−
0.
3±
1.
1
1.
7±
1.
3
0.
4±
1.
0
0.
6±
0.
3
−
0.
1±
0.
3
O
bs
tru
ct
iv
e
0.
7±
2.
4
2.
5±
1.
7
3.
0±
3.
4
1.
9±
2.
4
1.
3±
1.
1
C
A
D
 b
y 
R
ef
er
en
ce
 S
ta
nd
ar
d♮
N
or
m
al
−
1.
7±
2.
5
0.
26
3.
9±
2.
7
0.
55
−
1.
8±
1.
6
0.
34
0.
6±
2.
6
0.
40
1.
7±
0.
8
0.
34
N
on
- o
bs
tru
ct
iv
e
−
0.
1±
1.
9
2.
8±
1.
4
0.
9±
0.
9
2.
0±
1.
7
0.
3±
0.
3
O
bs
tru
ct
iv
e
−
0.
1±
2.
9
0.
8±
1.
9
3.
5±
5.
6
0.
7±
2.
9
1.
7±
1.
8
Pl
aq
ue
 C
om
po
sit
io
n♭
N
on
- c
al
ci
fie
d
0.
2±
1.
6
0.
47
1.
4±
1.
5
0.
44
1.
3±
0.
8
0.
84
3.
2±
1.
7
0.
09
0.
6±
0.
8
0.
33
Ca
lc
ifi
ed
0.
2±
2.
0
2.
9±
1.
5
2.
2±
4.
8
−
1.
2±
1.
1
0.
5±
0.
8
Im
ag
e 
R
ec
on
st
ru
ct
io
n
A
ID
R3
D
−
0.
5±
1.
3
0.
70
1.
3±
1.
7
0.
63
*
*
1.
6±
1.
1
0.
42
*
*
FB
P
−
1.
1±
2.
0
2.
5±
1.
9
*
*
−
0.
5±
2.
4
*
*
*
D
iff
er
en
ce
 b
et
w
ee
n 
re
ad
s 1
 a
nd
 2
 c
al
cu
la
te
d 
fro
m
 th
e 
m
ea
n 
TA
G
 a
m
on
g 
re
ad
er
s.
¶ T
he
re
 w
as
 a
 b
or
de
rli
ne
 si
gn
ifi
ca
nc
e 
be
tw
ee
n 
LC
X
 a
nd
 R
CA
 (p
=0
.05
).
€
B
M
I 2
5-
30
 w
as
 si
gn
ifi
ca
nt
ly
 d
iff
er
en
t f
ro
m
 B
M
I<
25
 an
d 
BM
I>
30
.
♯ N
on
-o
bs
tru
ct
iv
e 
de
fin
ed
 a
s m
os
t s
te
no
tic
 se
gm
en
t <
50
%
 d
ia
m
et
er
 st
en
os
is;
 o
bs
tru
ct
iv
e d
ef
in
ed
 as
 m
os
t s
te
no
tic
 se
gm
en
t ≥
50
%
 d
ia
m
et
er
 st
en
os
is.
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Chatzizisis et al. Page 15
♮ A
va
ila
bl
e 
in
 n
=1
4 
of
 2
0 
pa
tie
nt
s; 
ob
str
uc
tiv
e 
CA
D
 d
ef
in
ed
 a
s: 
>7
0%
 st
en
os
is 
at
 in
va
siv
e 
an
gi
og
ra
ph
y,
 su
m
m
ed
 st
re
ss
 sc
or
e 
≥4
 a
nd
 d
ef
ec
t i
de
nt
ifi
ed
 in
 th
e 
ve
ss
el
 te
rri
to
ry
 a
t r
es
t-s
tre
ss
 n
uc
le
ar
 m
yo
ca
rd
ia
l
pe
rfu
sio
n 
im
ag
in
g,
 o
r s
tre
ss
-in
du
ce
d 
se
ve
re
 h
yp
ok
in
es
is 
or
 a
ki
ne
sis
 in
 ≥
3/
16
 se
gm
en
ts 
at
 st
re
ss
 ec
ho
ca
rd
io
gr
ap
hy
.
♭ N
on
-c
al
ci
fie
d 
de
fin
ed
 a
s ≤
30
%
, a
nd
 c
al
ci
fie
d 
as
 >
30
%
 (3
) o
f p
laq
ue
 vo
lum
e w
ith
 >3
50
HU
 (1
9)
*
*
R
ep
ea
t T
A
G
 m
ea
su
re
m
en
ts 
w
er
e 
no
t p
er
fo
rm
ed
 fo
r F
BP
 re
co
ns
tru
ct
io
ns
.
Int J Cardiovasc Imaging. Author manuscript; available in PMC 2015 August 01.
